Loading
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Latest filing published 29 May 2026 for Brainstorm Cell Therapeutics INC.. Read the official filing
Filing timeline
BuySaleChaim Lebovits
Insider track record
Disclosed buys
8
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-2.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Chaim Lebovits: trading record in brief
Chaim Lebovits, listed as chief executive, appears in our data through filings on Brainstorm Cell Therapeutics Inc. shares, published by SEC (Form 4). Between 10 December 2021 and 26 February 2026, the trades on record add up to 22 filings.
No open-market sale appears; the market trades are 8 purchases worth €178k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 14 share grants.
Half of the purchases are above €11k and half below.
On 29 May 2026 came the latest disclosure, a share grant in Brainstorm Cell Therapeutics Inc. The latest purchase dates back some time: it was published 746 days ago, on 2 October 2024. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Chaim Lebovits
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,800,000 shares0Common StockSEC:0001104659-26-068339:0
120,000 shares0Common StockSEC:0001104659-25-000895:0
22,000 shares@ US$0.2281.3% of flowCommon StockSEC:0001104659-24-105215:0
Canonical exit: 29 Dec 2024 (T+90)
130,000 shares@ US$0.545719.0% of flowCommon StockSEC:0001104659-24-084334:0
Canonical exit: 16 Jul 2024 (T+90)
25,000 shares@ US$0.5793.8% of flowCommon StockSEC:0001104659-24-084343:0
Canonical exit: 19 Aug 2024 (T+90)
135,000 shares@ US$0.375313.4% of flowCommon StockSEC:0001104659-24-084337:0
Canonical exit: 4 Aug 2024 (T+90)
15,000 shares@ US$0.51832.0% of flowCommon StockSEC:0001104659-24-084344:0
Canonical exit: 26 Aug 2024 (T+90)
20,000 shares@ US$0.4652.5% of flowCommon StockSEC:0001104659-24-084341:0
Canonical exit: 8 Aug 2024 (T+90)
15,000 shares@ US$0.51992.1% of flowCommon StockSEC:0001104659-24-084336:0
Canonical exit: 18 Jul 2024 (T+90)
66,300 shares@ US$0.37436.6% of flowCommon StockSEC:0001104659-24-084339:0
Canonical exit: 5 Aug 2024 (T+90)
15,000 shares@ US$0.51832.0% of flowCommon StockSEC:0001104659-24-067529:0
25,000 shares@ US$0.5793.8% of flowCommon StockSEC:0001104659-24-064415:0
20,000 shares@ US$0.4652.5% of flowCommon StockSEC:0001104659-24-060889:0
66,300 shares@ US$0.37436.6% of flowCommon StockSEC:0001104659-24-058218:0
135,000 shares@ US$0.375313.4% of flowCommon StockSEC:0001104659-24-057784:0
15,000 shares@ US$0.51992.1% of flowCommon StockSEC:0001104659-24-051948:0
130,000 shares@ US$0.545719.0% of flowCommon StockSEC:0001104659-24-049027:0
305,198 shares0Common StockSEC:0001104659-24-034091:0
31,185 shares0Common StockSEC:0001104659-23-087819:0
75,000 shares0Common StockSEC:0001104659-23-048639:0
31,185 shares0Common StockSEC:0001104659-23-000634:0
31,185 shares0Common StockSEC:0001104659-21-148753:0
22 of 22 declarations
